Mobile Application for IBD Patients With Biologics

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

55 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-03-12

Study Completion Date

2021-02-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Monitoring of biologic treatment in patients with inflammatory bowel disease (IBD) is important given the increased risk of infections. In this study we aim to evaluate the use of a mobile application to guide IBD patients and facilitate the monitoring of biologic treatment.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of the SMART IBD App in Pediatric IBD

NCT07195123

Inflammatory Bowel Disease (IBD) IBD (Inflammatory Bowel Disease) IBD - Inflammatory Bowel Disease +4 more

RECRUITING NA

A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease

NCT03251118

Inflammatory Bowel Diseases Crohn's Disease Ulcerative Colitis +1 more

ACTIVE_NOT_RECRUITING

The Effect of MedicijnWijs on Adherence to Azathioprine Therapy in Adolescents With IBD

NCT05321485

Inflammatory Bowel Diseases Crohn Disease Ulcerative Colitis

UNKNOWN NA

Biological Therapy in Patients With Inflammatory Bowel Disease

NCT05599867

Quality of Life

UNKNOWN

The Inflammatory Bowel Disease - Anti-Inflammatory Diet (IBD-AID)

NCT04757181

Inflammatory Bowel Diseases

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Biologic treatment can induce and maintain remission in patients with inflammatory bowel disease (IBD). However, biologics are associated with increased risk of infections. Therefore, it is important to regularly monitor patients during the course of therapy. This process can be time consuming for patients as well as clinicians. Mobile applications, have the potential to guide patients and facilitate monitoring of biologic treatment. In this study we aim to evaluate the use of a mobile application to guide IBD patients during biologic treatment. Adult patients with diagnosis of IBD treated with biologics will be included. The mobile application with personalised content will give patients information about their treatment, reminders for example when blood tests and questionnaires to check for adverse events.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Inflammatory Bowel Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

This is a cohort study with assessments at baseline and after implementation of the mobile application. The study period will cover 6-12 months.

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Personalised mobile application for IBD patients

This is a cohort study with a 1 arm intervention group, without a control group. Patients included in this study will be invited to use a mobile application. The content and functionalities of this application are described in the intervention section.

Group Type EXPERIMENTAL

Personalised mobile application for IBD patients

Intervention Type DEVICE

Patients will use a mobile application for ±6months (exact period depends on interval of biologic treatment) with the following functionalities:

* Personal interactive timeline to prepare for biologic treatment with reminders for blood tests, a questionnaire to exclude contra-indications for biologic treatment (e.g. current infection) and a message from the gastroenterology nurse when blood tests results and the questionnaire have been checked. Only in case of abnormal results or answers patients will be contacted by telephone by their gastroenterology nurse, which is currently standard care.
* Information about the patients' diagnosis and biologic treatment.
* General information on e.g. IBD treatment, vaccinations, frequently used medical terms, preparing for outpatient visits, what to do in case of disease symptoms.

Patients will fill in a questionnaire to measure study outcomes at baseline and at the end of the study period.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Personalised mobile application for IBD patients

Patients will use a mobile application for ±6months (exact period depends on interval of biologic treatment) with the following functionalities:

* Personal interactive timeline to prepare for biologic treatment with reminders for blood tests, a questionnaire to exclude contra-indications for biologic treatment (e.g. current infection) and a message from the gastroenterology nurse when blood tests results and the questionnaire have been checked. Only in case of abnormal results or answers patients will be contacted by telephone by their gastroenterology nurse, which is currently standard care.
* Information about the patients' diagnosis and biologic treatment.
* General information on e.g. IBD treatment, vaccinations, frequently used medical terms, preparing for outpatient visits, what to do in case of disease symptoms.

Patients will fill in a questionnaire to measure study outcomes at baseline and at the end of the study period.

Intervention Type DEVICE